TCM as an Adjuvant Treatment in Breast Cancer Patients

Sponsor
Universiti Tunku Abdul Rahman
Study ID
NCT04843865
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Chinese Herbs — DIETARY_SUPPLEMENT
    Chinese Herbs

Study Details

Chinese herbs can alleviates the side effects caused by conventional treatment in breast cancer patients and affects the syndrome element differentiation by altering the specific set of proteomes at specific time point of treatment.

Key Dates

First listed
Apr 14, 2021
Start date
Apr 22, 2022
Status verified
Dec 2024
Primary completion
Dec 31, 2024
Completion
Dec 31, 2024

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Chinese Herbs
    Participants received standardized Chinese Herbs treatment orally twice daily for 1 week.

Primary Outcome Measure

Feasibility of the study (Adherence) [ Time Frame: Immediate post 1 week of Chinese Herbs intervention ]

Central Contacts

Find similar trials

Nationwide
Breast cancer trialsOncology trialsBreast oncology trialsWomen's health trials

Related Studies